selected publications
- Canonical AREs are tumor suppressive regulatory elements in the prostate. 2024 GET IT
- Correction: Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer. 2023 GET IT
-
hsa_circ_0092339 acts as a molecular sponge in castration-resistant prostate cancer via the hsa-mir-940/C-MYC axis.
Epigenomics.
2022
Academic Article
GET IT
Times cited: 1 - The cell cycle gene centromere protein K (CENPK) contributes to the malignant progression and prognosis of prostate cancer. Translational cancer research. 2022 Academic Article GET IT
- Downregulation of LOX promotes castration-resistant prostate cancer progression via IGFBP3. Journal of Cancer. 2021 Academic Article GET IT
-
A narrative review of proteolytic targeting chimeras (PROTACs): future perspective for prostate cancer therapy.
Translational andrology and urology.
2021
Review
GET IT
Times cited: 6 -
Transposon mutagenesis identifies chromatin modifiers cooperating with Ras in thyroid tumorigenesis and detects ATXN7 as a cancer gene.
Proceedings of the National Academy of Sciences of the United States of America.
2017
Academic Article
GET IT
Times cited: 16 -
Dual CARS and SHG image acquisition scheme that combines single central fiber and multimode fiber bundle to collect and differentiate backward and forward generated photons.
Biomedical optics express.
2016
Academic Article
GET IT
Times cited: 1 -
Multimodal nonlinear endo-microscopy probe design for high resolution, label-free intraoperative imaging.
Biomedical optics express.
2015
Academic Article
GET IT
Times cited: 18 -
Transformation by Hras(G12V) is consistently associated with mutant allele copy gains and is reversed by farnesyl transferase inhibition.
Oncogene.
2013
Academic Article
GET IT
Times cited: 41